FTC Sues to Block $3.5B Cencora Vet-Unit Sale to Covetrus
COR sits 45% above its 52-week low of $244.82 on light trading volume (0.2× avg).
Summary
The FTC sued in the Southern District of New York to block Cencora's $3.5 billion sale of its MWI Animal Health unit to Covetrus, with attorneys general from 13 states joining. The agency argues the combination would merge the two largest US distributors of veterinary medicines and clinic supplies, eliminating head-to-head price competition and raising costs for clinics and pet owners. Cencora agreed to the deal in February, so the challenge puts the divestiture — and the expected proceeds — on hold. J.P. Morgan analysts said they do not expect the FTC challenge to hurt Cencora's forecast and expect the company to defend the deal on strategic merits, while likely seeking alternative MWI transactions if it is ultimately blocked. Shares were up about 2% midday, suggesting the market sees limited earnings impact.
At the time of this announcement, COR was trading at $356.14 on NYSE in the Life Sciences sector, with a market capitalization of approximately $68B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.